name | Ranitidine |
classification | H2-receptor antagonist |
pharmacokinetics | absorption | Rapidly absorbed from the GI tract. | distribution | Distributed throughout the body; crosses the blood-brain barrier in small amounts. | metabolism | Metabolized primarily in the liver, and the primary metabolite is inactive. | excretion | Excreted primarily in the urine. |
|
suggested dosage | adults | usual | 150 mg twice daily | max | 300 mg/day |
| notes | Dosage may vary depending on the specific condition being treated. Always follow the prescribed dosage and consult a doctor for specific guidance. **Important Note:** The safety and availability of Ranitidine are currently under review due to potential N-nitrosodimethylamine (NDMA) contamination in some batches. Do not use any ranitidine product unless specifically approved for use in your region and by your healthcare provider. Consult the most up-to-date product information. |
|
indications | 1 | Peptic ulcer disease | 2 | Gastroesophageal reflux disease (GERD) | 3 | Zollinger-Ellison syndrome | 4 | Hypersecretory conditions |
|
safety in pregnancy | category | Category B | details | Limited data suggests no risk to the fetus during pregnancy. However, consult a doctor regarding use. Consult the most up-to-date medical information for current recommendations. |
|
safety in breastfeeding | details | Ranitidine passes into breast milk in small amounts. While generally considered safe, consult a doctor before breastfeeding. Consult the most up-to-date medical information for current recommendations. |
|
side effects | 1 | Headache | 2 | dizziness | 3 | constipation | 4 | diarrhea | 5 | nausea | 6 | vomiting | 7 | abdominal pain | 8 | rash | 9 | pruritus | 10 | liver function abnormalities | 11 | rarely, severe allergic reactions | 12 | aplastic anemia | 13 | leukopenia | 14 | thrombocytopenia | 15 | Note: Rare cases of N-nitrosodimethylamine (NDMA) have been reported in some batches in the past. Consult up-to-date safety information from regulatory bodies and manufacturers. |
|
alternatives | |
contraindications | 1 | Known hypersensitivity to ranitidine or other H2-receptor antagonists | 2 | Severe hepatic impairment | 3 | Use with caution in patients with a history of blood disorders. |
|
interactions | 1 | drug | Cimetidine | mechanism | Inhibits ranitidine metabolism | effect | May increase ranitidine levels | management | Monitor closely for adverse effects. Consult the prescribing information for specific guidance. |
| 2 | drug | Ketoconazole | mechanism | Inhibits ranitidine metabolism | effect | May increase ranitidine levels | management | Monitor closely for adverse effects. Consult the prescribing information for specific guidance. |
| 3 | drug | CYP450 inhibitors | mechanism | Potential inhibition of ranitidine metabolism | effect | May increase ranitidine levels | management | Monitor closely for adverse effects. Consult the prescribing information for specific guidance. |
| 4 | drug | warfarin | mechanism | Possible interaction (mechanism unclear) | effect | Potential increased bleeding risk | management | Monitor closely for bleeding problems. Consult the prescribing information for specific guidance. |
|
|
warnings and precautions | 1 | Caution in patients with pre-existing liver disease | 2 | Patients should be monitored for signs of hypersensitivity reactions | 3 | Monitor renal function in patients with renal impairment | 4 | Patients should be cautioned to avoid driving or operating machinery if dizziness occurs. Always consult the most up-to-date product information. |
|
additional information | 1 | Information on Ranitidine is constantly evolving. The most up-to-date safety data on N-nitrosodimethylamine (NDMA) contamination should be reviewed from official sources. Consult with your healthcare provider. | 2 | Do not use any ranitidine product not specifically approved for usage by your region. | 3 | Always consult a healthcare professional for appropriate use in your situation. The information provided is not a substitute for professional medical advice. |
|
patient info | |